Advertisement
Screener

ProQR Therapeutics N.V. (PRQR) Finance Income Cost

2.8 / 5 stars · 68/120 Roast Me

ProQR Therapeutics N.V. Finance Income Cost

ProQR Therapeutics N.V. (PRQR) reported Finance Income Cost of EUR 1.05 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-12.

Financial Statements › Expense Statement › Operating Expenses

ifrs-full:FinanceIncomeCost · last filed 2026-03-12

  • ProQR Therapeutics N.V. finance income cost for the quarter ending 2025-12-31 was 119.00K EUR, a 82.93% decline year-over-year.
  • ProQR Therapeutics N.V. finance income cost for the quarter ending 2025-09-30 was 280.00K EUR, a 40.30% decline year-over-year.
  • ProQR Therapeutics N.V. finance income cost for the quarter ending 2025-06-30 was 192.00K EUR, a 62.57% decline year-over-year.
  • ProQR Therapeutics N.V. finance income cost for the quarter ending 2025-03-31 was 455.00K EUR, a 6.76% decline year-over-year.
Period endFinance Income Cost 3 monthFinance Income Cost 3 month as first filedFinance Income Cost 6 monthFinance Income Cost 6 month as first filedFinance Income Cost 9 monthFinance Income Cost 9 month as first filedFinance Income Cost 12 monthFinance Income Cost 12 month as first filed
2025-12-31119.00K EUR
derived: 20-F 12 month − 6-K 9 month · filed 2026-03-12
399.00K EUR
derived: sum of 2 quarters · filed 2026-03-12
591.00K EUR
derived: sum of 3 quarters · filed 2026-03-12
1.05M EUR
20-F · filed 2026-03-12
2025-09-30280.00K EUR
6-K · filed 2025-11-06
472.00K EUR
derived: sum of 2 quarters · filed 2025-11-06
927.00K EUR
6-K · filed 2025-11-06
1.62M EUR
derived: sum of 4 quarters · filed 2026-03-12
2025-06-30192.00K EUR
6-K · filed 2025-08-07
647.00K EUR
6-K · filed 2025-08-07
1.34M EUR
derived: sum of 3 quarters · filed 2026-03-12
1.81M EUR
derived: sum of 4 quarters · filed 2026-03-12
2025-03-31455.00K EUR
6-K · filed 2025-05-08
1.15M EUR
derived: sum of 2 quarters · filed 2026-03-12
1.62M EUR
derived: sum of 3 quarters · filed 2026-03-12
2.13M EUR
derived: sum of 4 quarters · filed 2026-03-12
2024-12-31697.00K EUR
derived: 20-F 12 month − 6-K 9 month · filed 2026-03-12
1.17M EUR
derived: sum of 2 quarters · filed 2026-03-12
1.68M EUR
derived: sum of 3 quarters · filed 2026-03-12
2.17M EUR
20-F · filed 2026-03-12
2024-09-30469.00K EUR
6-K · filed 2025-11-06
982.00K EUR
derived: sum of 2 quarters · filed 2025-11-06
1.47M EUR
6-K · filed 2025-11-06
2.32M EUR
derived: sum of 4 quarters · filed 2026-03-12
2024-06-30513.00K EUR
6-K · filed 2025-08-07
1.00M EUR
6-K · filed 2025-08-07
1.85M EUR
derived: sum of 3 quarters · filed 2026-03-12
2.21M EUR
derived: sum of 4 quarters · filed 2026-03-12
2024-03-31488.00K EUR
6-K · filed 2025-05-08
1.33M EUR
derived: sum of 2 quarters · filed 2026-03-12
1.70M EUR
derived: sum of 3 quarters · filed 2026-03-12
2.17M EUR
derived: sum of 4 quarters · filed 2026-03-12
2023-12-31846.00K EUR
derived: 20-F 12 month − 6-K 9 month · filed 2026-03-12
1.21M EUR
derived: sum of 2 quarters · filed 2026-03-12
1.68M EUR
derived: sum of 3 quarters · filed 2026-03-12
1.14M EUR
20-F · filed 2026-03-12
2023-09-30363.00K EUR
6-K · filed 2024-11-07
833.00K EUR
derived: sum of 2 quarters · filed 2024-11-07
289.00K EUR
6-K · filed 2024-11-07
-915.00K EUR
derived: sum of 4 quarters · filed 2025-03-13
2023-06-30470.00K EUR
6-K · filed 2024-08-08
-74.00K EUR
6-K · filed 2024-08-08
-1.28M EUR
derived: sum of 3 quarters · filed 2025-03-13
-679.00K EUR
derived: sum of 4 quarters · filed 2025-03-13
2023-03-31-544.00K EUR
6-K · filed 2024-05-09
-1.75M EUR
derived: sum of 2 quarters · filed 2025-03-13
-1.15M EUR
derived: sum of 3 quarters · filed 2025-03-13
14.00K EUR
derived: sum of 4 quarters · filed 2025-03-13
2022-12-31-1.20M EUR
derived: 20-F 12 month − 6-K 9 month · filed 2025-03-13
-605.00K EUR
derived: sum of 2 quarters · filed 2025-03-13
558.00K EUR
derived: sum of 3 quarters · filed 2025-03-13
-264.00K EUR
20-F · filed 2025-03-13
-1.39M EUR
20-F · filed 2023-03-29
2022-09-30599.00K EUR
6-K · filed 2023-11-07
-620.00K EUR
6-K · filed 2022-11-09
1.76M EUR
derived: sum of 2 quarters · filed 2023-11-07
940.00K EUR
6-K · filed 2023-11-07
-2.00M EUR
6-K · filed 2022-11-09
642.00K EUR
derived: sum of 4 quarters · filed 2023-11-07
2022-06-301.16M EUR
6-K · filed 2023-08-03
-119.00K EUR
6-K · filed 2022-08-04
342.00K EUR
6-K · filed 2023-08-03
-1.38M EUR
6-K · filed 2022-08-04
43.00K EUR
derived: sum of 3 quarters · filed 2023-08-03
309.00K EUR
derived: sum of 4 quarters · filed 2023-08-03
2022-03-31-822.00K EUR
6-K · filed 2023-05-16
-1.26M EUR
6-K · filed 2022-05-05
-1.12M EUR
derived: sum of 2 quarters · filed 2023-05-16
-854.00K EUR
derived: sum of 3 quarters · filed 2023-05-16
-3.32M EUR
derived: sum of 4 quarters · filed 2023-05-16
2021-12-31-298.00K EUR
6-K · filed 2022-02-24
-32.00K EUR
derived: sum of 2 quarters · filed 2022-11-09
-2.50M EUR
derived: sum of 3 quarters · filed 2022-11-09
-1.89M EUR
20-F · filed 2024-03-13
-2.79M EUR
6-K · filed 2022-02-24
2021-09-30266.00K EUR
6-K · filed 2022-11-09
-2.20M EUR
derived: sum of 2 quarters · filed 2022-11-09
-2.49M EUR
6-K · filed 2022-11-09
-4.18M EUR
derived: sum of 4 quarters · filed 2022-11-09
2021-06-30-2.46M EUR
6-K · filed 2022-08-04
-2.76M EUR
6-K · filed 2022-08-04
-4.45M EUR
derived: sum of 3 quarters · filed 2022-08-04
-6.31M EUR
derived: sum of 4 quarters · filed 2022-08-04
2021-03-31-293.00K EUR
6-K · filed 2022-05-05
-1.99M EUR
derived: sum of 2 quarters · filed 2022-05-05
-3.85M EUR
derived: sum of 3 quarters · filed 2022-05-05
-4.54M EUR
derived: sum of 4 quarters · filed 2022-05-05
2020-12-31-1.69M EUR
6-K · filed 2022-02-24
-3.56M EUR
derived: sum of 2 quarters · filed 2022-02-24
-4.25M EUR
derived: sum of 3 quarters · filed 2022-02-24
-3.72M EUR
20-F · filed 2023-03-29
2020-09-30-1.86M EUR
6-K · filed 2021-11-04
-2.56M EUR
derived: sum of 2 quarters · filed 2021-11-04
-2.02M EUR
6-K · filed 2021-11-04
-2.96M EUR
derived: sum of 4 quarters · filed 2021-11-04
2020-06-30-697.00K EUR
6-K · filed 2021-08-05
-161.00K EUR
6-K · filed 2021-08-05
-1.10M EUR
derived: sum of 3 quarters · filed 2021-08-05
277.00K EUR
derived: sum of 4 quarters · filed 2021-08-05
2020-03-31536.00K EUR
6-K · filed 2020-05-07
-401.00K EUR
derived: sum of 2 quarters · filed 2021-02-25
974.00K EUR
derived: sum of 3 quarters · filed 2021-02-25
443.00K EUR
derived: sum of 4 quarters · filed 2021-02-25
2019-12-31-937.00K EUR
6-K · filed 2021-02-25
438.00K EUR
derived: sum of 2 quarters · filed 2021-02-25
-93.00K EUR
derived: sum of 3 quarters · filed 2021-02-25
402.00K EUR
20-F · filed 2022-04-29
2019-09-301.38M EUR
6-K · filed 2020-11-16
844.00K EUR
derived: sum of 2 quarters · filed 2020-11-16
1.34M EUR
6-K · filed 2020-11-16
1.21M EUR
derived: sum of 4 quarters · filed 2021-03-24
2019-06-30-531.00K EUR
6-K · filed 2020-08-06
-37.00K EUR
6-K · filed 2020-08-06
-165.00K EUR
derived: sum of 3 quarters · filed 2021-03-24
-239.00K EUR
derived: sum of 4 quarters · filed 2021-03-24
2019-03-31494.00K EUR
6-K · filed 2020-05-07
366.00K EUR
derived: sum of 2 quarters · filed 2021-03-24
292.00K EUR
derived: sum of 3 quarters · filed 2021-03-24
561.00K EUR
derived: sum of 4 quarters · filed 2021-03-24
2018-12-31-128.00K EUR
derived: 20-F 12 month − 6-K 9 month · filed 2021-03-24
-202.00K EUR
derived: sum of 2 quarters · filed 2021-03-24
67.00K EUR
derived: sum of 3 quarters · filed 2021-03-24
-792.00K EUR
20-F · filed 2021-03-24
2018-09-30-74.00K EUR
6-K · filed 2019-11-12
195.00K EUR
derived: sum of 2 quarters · filed 2019-11-12
-664.00K EUR
6-K · filed 2019-11-12
2018-06-30269.00K EUR
6-K · filed 2019-08-07
-590.00K EUR
6-K · filed 2019-08-07
2017-12-31-3.17M EUR
20-F · filed 2020-03-31
2017-06-30-1.18M EUR
6-K · filed 2018-08-08
-1.72M EUR
6-K · filed 2018-08-08
2016-12-31470.00K EUR
20-F · filed 2019-03-28
2015-12-316.17M EUR
20-F · filed 2018-03-30